A detailed history of Xtx Topco LTD transactions in A Tyr Pharma Inc stock. As of the latest transaction made, Xtx Topco LTD holds 83,328 shares of LIFE stock, worth $126,658. This represents 0.02% of its overall portfolio holdings.

Number of Shares
83,328
Previous 68,568 21.53%
Holding current value
$126,658
Previous $96,000 68.75%
% of portfolio
0.02%
Previous 0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$1.42 - $2.02 $20,959 - $29,815
14,760 Added 21.53%
83,328 $162,000
Q4 2023

Feb 13, 2024

SELL
$1.11 - $1.51 $5,911 - $8,042
-5,326 Reduced 7.21%
68,568 $96,000
Q3 2023

Nov 13, 2023

SELL
$1.55 - $2.23 $149,623 - $215,264
-96,531 Reduced 56.64%
73,894 $116,000
Q2 2023

Aug 14, 2023

BUY
$1.72 - $2.57 $293,131 - $437,992
170,425 New
170,425 $368,000
Q3 2021

Nov 12, 2021

SELL
$4.22 - $12.48 $51,758 - $153,067
-12,265 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$3.62 - $4.88 $44,399 - $59,853
12,265 New
12,265 $60,000

Others Institutions Holding LIFE

About aTYR PHARMA INC


  • Ticker LIFE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,625,000
  • Market Cap $43.5M
  • Description
  • aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...
More about LIFE
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.